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The Challenge
We are developing transgenic cattle 
resistant to an important disease, 
trypanosomiasis, that could have a major 
impact across Africa. Our long-term aim 
is to generate genetically modified cattle, 
which carry a gene that imparts resistance 
to African trypanosomes. The gene, 
APOL1, encodes for the pore forming 
protein component apolipoprotein L-I of 
trypanosome lytic factors (TLFs).
Broader Impacts
l Trypanosome resistant cattle 
will survive in the tsetse belt 
–10 million square miles
l The women who till the land 
by hand (90% of sub-Saharan 
Africa) can use cattle for:
 l Haulage, traction and soil 
fertility –crop production 
could increase 10-fold
 l Have milk and meat products 
–less vulnerable to critical 
harvest time imposed by 
plants
 l Have a store of wealth for 
future investments 
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Phenotyping and field studies





 Lipids and 
Cholesterols
Trypanosome Lytic Factor
Trypanosome lytic factor is a high-
density lipoprotein (HDL) (the good 
cholesterol) that circulates in the blood 
of some primates. It is composed of 
lipids and three proteins, apolipoprotein 
A-I (APOA-I), haptoglobin related 
protein (HPR), and the pore forming 
apolipoprotein L-I (APOL1).
Established Bovine Fibroblasts Select Ideal CRISPR Guide RNA
Expressing APOL1 in Mice APOL1 Protects Against 
Trypanosome Infection
1. Native APOL1
2. Transgenic mouse #1 high-density lipoprotein
3. Transgenic mouse #2 high-density lipoprotein
4. Transgenic mouse #3 high-density lipoprotein
APOL1 is Secreted and Loaded 
onto Mouse HDL Complexes
APOL1 55 kDa 
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1. Native APOL1
2. 1 ul of Heterozygous serum
3. 2 ul of Heterozygous serum
4. 1 ul of Homozygous serum
5. 2 ul of Homozygous serum
APOL1 55 kDa 
1 2 3 4 5
Expression Level is Copy-
Number Dependent
Human and Cattle-Infective T. b. rhodesiense
Hydrodynamic Gene Delivery
So much plasmid solution injected so quickly, 
cells swell and break open, allowing plasmid 
to enter; when cells repair themselves, 
plasmid is inside cell. 
Mouse cell Mouse cells express 
gene on plasmid and 
secrete protein 
Wild Type (9) 
Tg-APOL1 HET (6) 
Tg-APOL1 HOM (6)
Tg-APOL1 HET + HPR (4)


















Days Post Infection 
l African Bos indicus breed
l High resistance to ticks and heat
l Can endure scarcity of water
l Can live on low quality feed
Mechanism of Action of 
Trypanosome Lytic Factor
TLF binds in the flagellar pocket to a 
receptor (mediated by HPR) and is 
endocytosed by the parasite. TLF is 
activated in the acidic endosome and 
APOL1 is released from the particle and 
inserts into the membrane forming a 
monovalent ionic pore. 
The activation can be blocked by the weak 
base ammonium chloride (NH4Cl), which 
neutralizes the endolysosomal system. The 
pore allows the equilibration of ions down 
their concentration gradients, leading to 
the dissipation of the membrane potential 
and the influx of water, such that the 





CRISPR/Cas9 Mediated Insertion of Targeting Construct
We have two targeted 
transgenic Boran fibroblast 
lines that have been taken 
to the blastocyst stage in 
vitro. These will be used 
to generate transgenic 
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